Search results for "VTE prophylaxis"
acp-hosp0000
31 VTE prophylaxis for CVA or Clinical Careintracranial hemorrhage. 32 Rx antithrombotic for CVA or TIA Clinical Care. ... ACE = angiotensin-converting-enzyme; ARB = angiotensin IIreceptor blockers; ASA = acetylsalicylic acid; BMI = body massindex; CAD = coronary artery disease; VTE = venous throm-boembolism; CVA = cerebrovascular accident; LVEF = left ven-tricular ejection fraction;
https://acphospitalist.acponline.org/archives/2014/09/acph-201409-coding_t1.pdf
10 Sep 2014
Pharmacologic prophylaxis use doesn't lower VTE risk, study finds
Hospitals that have higher rates of pharmacologic prophylaxis for venous thromboembolism (VTE) don't have lower rates of VTE, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2014/08/27/1.htm
27 Aug 2014
More severe heart failure patients have higher VTE risk
Inpatients with more severe heart failure are at higher short-term risk of venous thromboembolism (VTE) than those with less severe heart failure, an analysis found.
https://acphospitalist.acponline.org/weekly/archives/2014/07/09/3.htm
9 Jul 2014
Prophylactic anticoagulation associated with better all-cause mortality vs. mechanical devices for VTE prevention in critically ill
Critically ill patients should receive prophylactic anticoagulation over mechanical device prophylaxis for preventing venous thromboembolism (VTE), a study found.
https://acphospitalist.acponline.org/weekly/archives/2014/04/30/1.htm
30 Apr 2014
Top Docs
Our call for nominations last spring yielded an impressive number of nominees, from which our editorial board selected the ten featured here. These physicians have done admirable work in patient rounding, resident education, technology, workload balance, and more.
https://acphospitalist.acponline.org/archives/2013/11/coverstory.htm
15 Nov 2013
Recent Research
Reducing MRSA in the ICU, rivaroxaban in heart failure, warfarin bridging during cardiac device surgery, and more.
https://acphospitalist.acponline.org/archives/2013/08/rr.htm
15 Aug 2013
Aspirin noninferior to dalteparin for VTE prophylaxis following hip replacement
Aspirin therapy for 28 days may be a reasonable alternative to low-molecular-weight heparin (LMWH) for extended venous thromboembolism (VTE) prophylaxis among hip replacement patients who have already received LMWH for 10 days.
https://acphospitalist.acponline.org/weekly/archives/2013/06/05/2.htm
5 Jun 2013
Recent Research
Rivaroxaban and CV events, afib and cognitive impairment, and more.
https://acphospitalist.acponline.org/archives/2013/05/rr.htm
15 May 2013
Caring for cancer patients
Knowledge about the effects of cancer treatments on organ systems and the potential risks of surgery unique to cancer patients is becoming key.
https://acphospitalist.acponline.org/archives/2013/02/cancer.htm
15 Feb 2013
For inpatient VTE prevention, rivaroxaban noninferior to enoxaparin
Rivaroxaban is noninferior to enoxaparin for standard-duration venous thromboembolism (VTE) prophylaxis in acutely ill patients, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2013/02/13/3.htm
13 Feb 2013